Results

Total Results: 1,335 records

Showing results for "colon cancer screening".
Users also searched for: colorectal cancer screening

301. Diagnostic Imaging | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/diagnostic-imaging?page=1
     September 13, 2012 - Treatment Modalities Systematic Review Archived February 29, 2012 Fecal DNA Testing in Screening … Review Research Protocol Archived January 18, 2012 Pulmonary Arterial Hypertension: Screening … Effectiveness Review and Meta-Analysis Systematic Review Archived November 14, 2011 Screening … Research Protocol Archived May 18, 2011 Comparative Effectiveness of Fecal DNA Testing in Screening

302. Aspirin or Nonsteroidal Anti-inflammatory Drugs for the Primary Prevention of Colorectal Cancer (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/c-7ARQE9RuXKjjpeLABkaH
     March 01, 2007 - colorectal cancer, and not to individuals with familial adenomatous polyposis, hereditary nonpol- yposis colon … cancer syndromes (Lynch I or II), or a history of colorectal cancer or adenomas. … Progress in earlier detection and removal of precancerous polyps through screening, in addition to improved … Drugs and colon cancer. Pharmacoepidemiol Drug Saf. 1998;7:99-106. [PMID: 15073733] 18. … Aspirin use and reduced risk of fatal colon cancer. N Engl J Med. 1991;325:1593-6.

303. Decision Support Tools for Screening and Treatment Decisions in Early Cancer | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/cancer-decision-support-tools/research-protocol
     December 01, 2019 - mutations (breast cancer) Lynch syndrome or presence of deleterious mismatch repair gene mutations (colon … cancer, endometrial cancer) Familial Adenomatous Polyposis Coli (FAP; colon cancer) Significant … Screening for Ovarian Cancer: U.S. … Practice bulletin no. 122: Breast cancer screening. … Screening for testicular cancer: U.S.

304. Decision Support Tools for Screening and Treatment Decisions in Early Cancer | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/cancer-decision-support-tools/research-protocol
     November 12, 2013 - mutations (breast cancer) Lynch syndrome or presence of deleterious mismatch repair gene mutations (colon … cancer, endometrial cancer) Familial Adenomatous Polyposis Coli (FAP; colon cancer) Significant … Screening for Ovarian Cancer: U.S. … Practice bulletin no. 122: Breast cancer screening. … Screening for testicular cancer: U.S.

305. CT Scans | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/ct-scans
     September 12, 2019 - for Coronary Artery Disease Decision Aid Archived March 9, 2016 Is Lung Cancer Screening … Colorectal Cancer Systematic Review Archived February 29, 2012 Fecal DNA Testing in Screening … Research Protocol Archived May 18, 2011 Comparative Effectiveness of Fecal DNA Testing in Screening

306. Screening for Ovarian Cancer: A Brief Evidence Update (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/k2QHcwuK4NkvxFXhvGrbwY
     May 01, 2004 - Available screening tests, however, were found to be inadequately sensitive/specific for screening and … What are the harms of screening? … Screening for ovarian cancer. … Usefulness of mass screening for ovarian carcinoma using transvaginal ultrasonography. … 8 Dates include January 1995–December 2002 1 exp Ovarian Neoplasms/ or ovarian cancer.mp. 2 exp Mass

307. Archived: Breast and Ovarian Cancer: BRCA Genetic Testing, September 2005 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer--brca-testing-ovarian-cancer-screeni
     September 15, 2005 - screening for women with BRCA1 or BRCA2 gene mutations. … The USPSTF has made recommendations on mammography screening for breast cancer, screening for ovarian … The USPSTF examined the available evidence on harms of screening and intervention. … Breast-ovarian cancer screening. Number 239, August 2000. … Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium.

308. Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/studies/index.html?page=254
     January 01, 2024 - Screening recommendations from various sources are reviewed, and the authors note that screening for … Keywords: Cancer, Care Management, Diagnostic Safety and Quality, Screening Millenson ML , … Preventive Services Task Force (USPSTF) recommendations for screening for cardiovascular disease risk … Screening for cardiovascular disease risk with electrocardiography. … Preventive Services Task Force (USPSTF), Cardiovascular Conditions, Screening, Risk, Prevention, Guidelines

309. Diverticulosis and Diverticulitis | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/diverticulosis-and-diverticulitis
     October 12, 2020 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …

310. Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/studies/index.html?page=420
     January 01, 2024 - Understanding how different populations think about CRC screening may be critical in promoting screening … This review aimed to update the evidence on screening and treating children for speech and language delay … It concluded that several screening tools can accurately identify children for diagnostic evaluations … Screening for speech and language delay in children 5 years old and younger: a systematic review. … Preventive Services Task Force (USPSTF), Children/Adolescents, Screening Andrews RM AHRQ

311. Section 2. Recommendations for Adults (continued) | Agency for Healthcare Research and Quality
     www.ahrq.gov/prevention/guidelines/guide/section2c.html
     June 01, 2014 - Timing of Screening The optimal interval for screening is uncertain. … Timing of Screening No evidence was found about appropriate intervals for screening. … Timing of Screening Evidence is lacking about optimal intervals for repeated screening. … Assessment Women with BRCA1 and BRCA2 genetic mutations, the Lynch syndrome (hereditary nonpolyposis colon … cancer), or a family history of ovarian cancer are at increased risk for ovarian cancer.

312. Modeling Study: Colorectal Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-modeling-study18/colorectal-cancer-screening
     May 18, 2021 - Screening Component The models’ screening components allow for interruption of the adenoma-carcinoma … Multiple ages to begin screening (45, 50, 55 years) and end screening (70, 75, 80, 85 years)and screening … Within each class, estimated LYG from screening increased when screening was initiated in the models … Modality Screening interval, y Age to begin screening, y Age to end screening, … modality, age to begin screening-age to end screening, interval.

313. Archived: Menopausal Hormone Therapy: Preventive Medication, 2002 and 2005 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/v2-menopausal-hormone-therapy-preventive-medicatio
     May 09, 2005 - cancer (HR, 0.63; adjusted 95% CI, 0.32-1.24 and RH, 0.81; 95% CI, 0.46-1.45, respectively), but the … cancer (RR, 0.80; 95% CI, 0.74-0.86) and a 19-percent reduction in rectal cancer (RR, 0.81; 95% CI, … , and pulmonary embolism, outweighed the evidence of benefit for fractures and possible benefit for colon … cancer." 6 This study showed an increased invasive breast cancer incidence (HR, 1.26; nominal 95% CI … Screening for osteoporosis in postmenopausal women: recommendations and rationale.

314. Archived: Menopausal Hormone Therapy: Preventive Medication, 2002 and 2005 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/menopausal-hormone-therapy-preventive-medication-2002-2005
     May 09, 2005 - cancer (HR, 0.63; adjusted 95% CI, 0.32-1.24 and RH, 0.81; 95% CI, 0.46-1.45, respectively), but the … cancer (RR, 0.80; 95% CI, 0.74-0.86) and a 19-percent reduction in rectal cancer (RR, 0.81; 95% CI, … , and pulmonary embolism, outweighed the evidence of benefit for fractures and possible benefit for colon … cancer." 6 This study showed an increased invasive breast cancer incidence (HR, 1.26; nominal 95% CI … Screening for osteoporosis in postmenopausal women: recommendations and rationale.

315. Hormone Therapy for the Prevention of Chronic Conditions in Postmenopausal Women: Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/s9NcVWwGErrH9b9M_6NryW
     May 01, 2005 - cancer (HR, 0.63; adjusted 95% CI, 0.32-1.24 and RH, 0.81; 95% CI, 0.46-1.45, respectively), but the … .7 A meta-analysis of 18 observational studies of postmenopausal women reported a 20% reduction in colon … cancer (RR, 0.80; 95% CI, 0.74-0.86) and a 19% reduction in rectal cancer (RR, 0.81; 95% CI, 0.72-0.92 … cancer.”6 This study showed an increased invasive breast cancer incidence (HR, 1.26; nominal 95% CI … Screening for osteoporosis in postmenopausal women: recommendations and rationale.

316. Archived: Risk Factors and Other Epidemiologic Considerations for Cervical Cancer Screening: A Narrative Review for the U.S. Preventive Services Task Force: Cervical Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/risk-factors-and-other-epidemiologic-considerations-for-cervical-cancer-screening-a-narrative-review-for-the-us-preventive-services-task-force/cervical-cancer-screening-2012
     October 15, 2011 - to begin and end screening. … NI Cancer Screening Programmes. History of the cervical screening programme. … Cervical Cancer Screening: Screening Programme. … for continued screening. … Start Screening Age to Stop Screening Screening Interval Australia 59 1991 18 * 69

317. SRDR - Systematic Review Data Repository |
     srdr.ahrq.gov/projects/1520/studies/186763
     January 01, 2019 - uncomplicated ACD and aged between 20 and 85 years Comments ( 0 ) | Post/View Exclusion criteria colon … cancer, intestinal bowel disease, pregnancy, severe comorbidities, acute appendicitis, history of colonic … surgery or colon cancer Comments ( 0 ) | Post/View Specific population?

318. The e-Autopsy/e-Biopsy: a systematic chart review to increase safety and diagnostic accuracy. | PSNet
     psnet.ahrq.gov/issue/e-autopsye-biopsy-systematic-chart-review-increase-safety-and-diagnostic-accuracy
     May 12, 2021 - is illustrated with three diagnoses: ectopic pregnancy , abdominal aortic aneurysms , and advanced colon … cancer. … May 12, 2021 Multilevel factors associated with time to biopsy after abnormal screening

319. Template for Reports Developed (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/fiber-intake-draft-report-appendix-a-b.pdf
     February 25, 2025 - bread improves bowel function and decreases the concentrations of some compounds that are putative colon … cancer risk markers in middle-aged women and men. … 23674271 Evaluation of the effect of blackcurrant products on gut microbiota and on markers of risk for colon … cancer in humans Phytother Res Molan, A. … Full article not available 69 9701196 Modulation of fecal markers relevant to colon cancer risk:

320. Disposition of Comments: Management of Colonic Diverticulitis (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diverticulitis-comments.pdf
     October 12, 2020 - reason for the age 50 cutpoint (used by 5 studies) is to match general population guidance for CRC screening